Edition:
United States

Obalon Therapeutics Inc (OBLN.OQ)

OBLN.OQ on NASDAQ Stock Exchange Global Market

7.85USD
15 Dec 2017
Change (% chg)

$0.03 (+0.38%)
Prev Close
$7.82
Open
$7.74
Day's High
$7.90
Day's Low
$7.74
Volume
42,516
Avg. Vol
9,653
52-wk High
$13.18
52-wk Low
$7.14

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.47 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.60 1.60 1.60

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 5 3.37 3.60 3.00 3.37
Quarter Ending Mar-18 4 4.04 4.30 3.70 4.80
Year Ending Dec-17 5 9.54 9.80 9.00 8.80
Year Ending Dec-18 5 23.13 24.87 18.20 25.98
Earnings (per share)
Quarter Ending Dec-17 5 -0.47 -0.43 -0.50 -0.46
Quarter Ending Mar-18 4 -0.41 -0.28 -0.46 -0.40
Year Ending Dec-17 5 -1.95 -1.90 -1.98 -1.79
Year Ending Dec-18 5 -1.72 -1.61 -1.86 -1.73

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 2.90 2.79 0.11 3.75
Quarter Ending Jun-17 1.72 1.96 0.25 14.31
Quarter Ending Mar-17 1.29 1.47 0.18 14.11
Quarter Ending Dec-16 0.70 0.77 0.07 10.71
Quarter Ending Sep-16 0.70 0.77 0.07 10.04
Earnings (per share)
Quarter Ending Sep-17 -0.45 -0.55 0.10 -21.68
Quarter Ending Jun-17 -0.44 -0.46 0.02 -5.14
Quarter Ending Mar-17 -0.41 -0.47 0.06 -13.94
Quarter Ending Dec-16 -0.34 -0.51 0.17 -50.00
Quarter Ending Sep-16 -0.92 -5.46 4.54 -491.36

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3.37 3.37 3.43 3.76 3.37
Quarter Ending Mar-18 4.04 4.04 4.04 4.58 4.80
Year Ending Dec-17 9.54 9.54 9.64 10.11 8.80
Year Ending Dec-18 23.13 23.13 23.17 24.72 25.98
Earnings (per share)
Quarter Ending Dec-17 -0.47 -0.47 -0.47 -0.47 -0.46
Quarter Ending Mar-18 -0.41 -0.41 -0.41 -0.38 -0.40
Year Ending Dec-17 -1.95 -1.95 -1.95 -1.86 -1.79
Year Ending Dec-18 -1.72 -1.72 -1.72 -1.65 -1.73

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 1
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 0 1
Earnings
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0